Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
In the latest session, Takeda Pharmaceutical Co ADR (NYSE: TAK) closed at $15.02 down -0.33% from its previous closing price of $15.07. In other words, the price has decreased by -$0.33 from its previous closing price. On the day, 2.11 million shares were traded. TAK stock price reached its highest trading level at $15.095 during the session, while it also had its lowest trading level at $14.93.
Ratios:
For a deeper understanding of Takeda Pharmaceutical Co ADR’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 18.36 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 9.49. For the most recent quarter (mrq), Quick Ratio is recorded 0.52 and its Current Ratio is at 1.01. In the meantime, Its Debt-to-Equity ratio is 0.73 whereas as Long-Term Debt/Eq ratio is at 0.65.
On March 16, 2023, BofA Securities Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $20.
Cowen Upgraded its Market Perform to Outperform on July 19, 2022, whereas the target price for the stock was revised from $21 to $24.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Aug 23 ’24 when Giles Richard Platford bought 19,073 shares for $14.94 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TAK now has a Market Capitalization of 47535898624 and an Enterprise Value of 4728700796928. As of this moment, Takeda’s Price-to-Earnings (P/E) ratio for their current fiscal year is 69.12, and their Forward P/E ratio for the next fiscal year is 22.72. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.45. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.57 while its Price-to-Book (P/B) ratio in mrq is 1.02. Its current Enterprise Value per Revenue stands at 1.032 whereas that against EBITDA is 3.834.
Stock Price History:
The Beta on a monthly basis for TAK is 0.27, which has changed by 0.13358486 over the last 52 weeks, in comparison to a change of 0.10500872 over the same period for the S&P500. Over the past 52 weeks, TAK has reached a high of $15.53, while it has fallen to a 52-week low of $12.80. The 50-Day Moving Average of the stock is 1.04%, while the 200-Day Moving Average is calculated to be 5.61%.
Shares Statistics:
For the past three months, TAK has traded an average of 2.16M shares per day and 2137050 over the past ten days. A total of 3.15B shares are outstanding, with a floating share count of 3.15B. Insiders hold about 0.02% of the company’s shares, while institutions hold 5.05% stake in the company. Shares short for TAK as of 1749772800 were 6498112 with a Short Ratio of 3.00, compared to 1747267200 on 6244158. Therefore, it implies a Short% of Shares Outstanding of 6498112 and a Short% of Float of 0.21.
Dividends & Splits
According to the company, the forward annual dividend rate for TAK is 0.33, from 196.0 in the trailing year. Against a Trailing Annual Dividend Yield of 13.005973The stock’s 5-year Average Dividend Yield is 4.69.
